This article is a part of your HHCN+ Membership
Amedisys Inc. (Nasdaq: AMED) has a new CEO. During the Transition of power, we are likely to find out a lot about what the company’s future looks like.
As one of the largest, independent aging-in-place providers in the country, Amedisys’ next moves will send ripple effects throughout the home health and hospice space. And, by the day, it’s becoming clearer that the Amedisys of the last 10 years will not be the Amedisys of tomorrow.
Sign up for HHCN + to read this exclusive content.
Individual Membership $400 per year
Purchase
Group 2–5 members $380 per year*
Purchase
Need more than 5 members? Contact us for more information.
* per member
The post ‘Aggressively Moving Into Higher-Acuity Care’: Amedisys’ Future After Ceo Transition appeared first on Home Health Care News.
